(Q43684700)

English

Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

scientific article published in August 2001

Statements

Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study (English)
Bunjes D
Buchmann I
Duncker C
Kotzerke J
Wiesneth M
Stefanic M
Harsdorf SV
Glatting G
Grimminger W
Karakas T
Munzert G
Döhner H
Bergmann L
Reske SN
1 August 2001
565-572

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit